DEF 14A: Prestige Consumer Healthcare Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Pay, and Certificate Amendment

Prestige Consumer Healthcare Inc. is holding its 2024 Annual Meeting of Stockholders on August 6, 2024, to vote on key proposals including the election of directors, ratification of the independent auditor, executive compensation, and an amendment to the company's certificate of incorporation.

Summary

• Prestige Consumer Healthcare Inc. will hold its 2024 Annual Meeting of Stockholders on August 6, 2024.
• Stockholders of record as of June 10, 2024, are entitled to vote.
• The meeting will address the election of seven directors, ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year ending March 31, 2025, an advisory vote on executive compensation, and approval of an amendment to the Amended and Restated Certificate of Incorporation.
• The Board of Directors recommends voting 'FOR' all director nominees and 'FOR' Proposals 2, 3, and 4.
• The company achieved revenue of $1,125 million and adjusted EPS of $4.21 in fiscal year 2024.
• Adjusted Free Cash Flow was approximately $240 million.
• The company's leverage profile is at its lowest in its history.
• The Board is seeking approval to amend the Certificate of Incorporation to limit the monetary liability of certain senior corporate officers for breach of duty of care and to remove provisions related to a former stockholder.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting financial achievements and strategic initiatives. While acknowledging challenges, the overall tone is optimistic and confident in the company's future prospects.

Positives

• The company achieved its lowest year-end leverage profile in its history.
• Free cash flow grew approximately 8% year-over-year.
• The company delivered a stable year-over-year financial performance despite supply chain challenges.
• The company's strategy of deleveraging and brand-building has been successful.
• The company has a diverse and experienced Board of Directors.
• The company emphasizes corporate sustainability and has published its inaugural corporate sustainability report.
• The company has a robust Code of Conduct and Ethics.
• The company has stock ownership guidelines for directors and executive officers to align their interests with stockholders.

Negatives

• The company faced highly unusual short-term supply chain challenges late in the fiscal year.
• One director, Natale S. Ricciardi, is retiring from the board due to reaching the mandatory retirement age.

Risks

• The company faces risks related to economic conditions, industry competition, cybersecurity, and compliance.
• The company's future performance depends on its ability to manage these risks effectively.

Future Outlook

The company is well-positioned with a large base of optimal capital to reinforce capital allocation priorities and drive shareholder value over time.

Management Comments

• Fiscal 2024 delivered a milestone year for our company in multiple ways.
• We achieved the lowest year-end leverage profile in the Company's history, grew free cash flow and delivered a stable year-over-year financial performance in spite of highly unusual short-term supply chain challenges late in the year.
• Our ability to deliver these results against a very dynamic consumer and retail environment is the result of our proven business strategy and the benefits of a diverse portfolio of trusted brands.
• With consistent execution and patience, we are incrementally well positioned with a large base of optimal capital that can reinforce our capital allocation priorities to drive shareholder value over time.

Industry Context

Prestige Consumer Healthcare operates in the consumer healthcare industry, competing with other over-the-counter (OTC) and personal care product companies. The company's focus on brand-building and deleveraging aligns with industry trends of emphasizing long-term value creation and financial stability.

Comparison to Industry Standards

• The document mentions a peer group of companies including Church & Dwight, Edgewell Personal Care, and Helen of Troy.
• These companies are also in the consumer products space and are used for benchmarking executive compensation.
• Prestige's performance metrics, such as revenue growth and EBITDA margins, are likely compared against these peers to assess its relative performance.
• The document highlights Prestige's deleveraging efforts, which is a common strategy among companies seeking to improve financial flexibility and shareholder returns.

Corporate Governance

Stakeholder Impact

• Shareholders: The company's performance and strategic decisions directly impact shareholder value.
• Employees: The company's compensation policies and work environment affect employee morale and retention.
• Customers: The company's commitment to quality and sustainability influences customer trust and loyalty.
• Suppliers: The company's Supplier Code of Conduct outlines environmental and social responsibilities.
• Communities: The company's corporate social responsibility initiatives impact the communities in which it operates.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the Proxy Statement.
• The company will hold its Annual Meeting of Stockholders on August 6, 2024.
• The company will continue to execute its strategy of deleveraging and brand-building.
• The company will publish its 2024 corporate sustainability report later in 2024.

Key Dates

Keywords

Proxy Statement, Annual Meeting, Board of Directors, Stockholders, Executive Compensation, Corporate Governance, Director Election, Auditor Ratification, Certificate of Incorporation, ESG, Financial Performance, Prestige Consumer Healthcare